SuperGen, Inc. to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference November 5, 2007

DUBLIN, Calif., Oct. 30 /PRNewswire-FirstCall/ -- SuperGen Inc. , a pharmaceutical company dedicated to the discovery, rapid development and commercialization of therapies for solid tumors and hematological malignancies, today announced that James S. Manuso, Ph.D., President and Chief Executive Officer is scheduled to present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference on Nov. 5, 2007, at The New York Palace Hotel.

SuperGen's presentation at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference is scheduled to begin at 9:30 a.m. EST. A live webcast of the presentation will be available on the investor relations section of the Company's Web site at www.supergen.com. The webcast will be archived for 90 days.

About SuperGen

Based in Dublin, Calif., SuperGen, Inc. is a pharmaceutical company dedicated to the discovery, rapid development and commercialization of therapies for solid tumors and hematological malignancies. SuperGen is developing a number of therapeutic anticancer products focused on kinase and cell signaling inhibitors and DNA methyltransferase inhibitors. For more information about SuperGen, please visit http://www.supergen.com.

tenns@supergen.commary.vegh@supergen.com

CONTACT: Timothy L. Enns, SVP, Corporate Communications & Business
Development, +1-925-560-0100, tenns@supergen.com, or Mary M. Vegh, Manager,
Investor Relations, +1-925-560-2845, mary.vegh@supergen.com, both of
SuperGen, Inc.

Web site: http://www.supergen.com/